A(2a) adenosine receptors: Guanine nucleotide derivative regulation in porcine striatal membranes and digitonin soluble fraction

Neurochemistry International

Volumn 33, Issue 2, 1998, Pages 121-129

  Costa, Barbara ^a   Lucacchini, Antonio ^a   Martini, Claudia ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; DIGITONIN; GUANINE NUCLEOTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LIPID; RADIOLIGAND; ADENOSINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE; PHENETHYLAMINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; GEL FILTRATION; MEMBRANE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; REGULATORY MECHANISM; SCATCHARD PLOT; SOLUBILIZATION; SWINE; ANIMAL; CELL MEMBRANE; GEL CHROMATOGRAPHY; METABOLISM; SOLUBILITY;

ADENOSINE; ANIMALS; CELL MEMBRANE; CHROMATOGRAPHY, GEL; CORPUS STRIATUM; DIGITONIN; GUANINE NUCLEOTIDES; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MOLECULAR WEIGHT; PHENETHYLAMINES; RECEPTORS, PURINERGIC P1; SOLUBILITY; SWINE;

EID: 0032129207     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00019-9     Document Type: Article

References (32)

1. 2 adenosine receptor binding subunit by photoaffinity crosslinking. Proc. Natl. Acad. Sci. U.S.A. 86, 6572-6576.
2. 3H]SCH58261 to coronary artery membranes. Circ. Res. 79, 1153-1160.
3. i) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
4. Chern, Y., King, K., Lai, H.L., Lai, H.T., 1992. Molecular cloning of a novel adenosine receptor gene from rat brain. Biochem. Biophys. Res. Comm. 185, 304-309.
5. Daly, J.W., Butts-Lamb, P., Padgett, W., 1983. Subclasses of adenosine receptors in the central nervous system. Interaction with caffeine and related methylxanthines. Cell. Mol. Neurobiol. 1, 69-80.
6. Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Daly, J.W., Harden, T.K., Jacobson, K.A., Leff, P., Williams, M., 1994. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46, 143-156.
7. 2 adenosine receptor. Mol. Brain Res. 15, 62-66.
8. 1 receptors from rat brain. Biochem. J. 257, 413-418.
9. 2a adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase. Mol. Pharmacol. 41, 352-359.
10. Jacobson, K.A., van Galen, P.J.M., Williams, M., 1992. Adenosine receptors: pharmacology, structure-activity relationship, and therapeutic potential. Med. Chem. 35, 407-421.
11. 2 receptor. J. Pharmacol. Exp. Ther. 251, 888-893.
12. 2a-adenosine receptors: stability and antagonist binding. Arch. Biochem. Bioph. 305, 611-617.
13. Kenakin, T., 1996. The classification of seven transmembrane receptors in recombinant expression systems. Pharmcol. Rev. 48, 413-463.
14. Kilpatrick, B.F., Caron, M.G., 1983. Agonist binding promotes a guanine nucleotide reversible increase in the apparent size of the bovine anterior pituitary dopamine receptor. J. Biol. Chem. 258, 13528-13534.
15. 1 adenosine receptor. Mol. Pharmacol. 35, 450-457.
16. Londos, C., Wolff, J., 1977. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 74, 5482-5486.
17. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
18. Lumbird, L.E., Lefkowitz, K.J., 1978. Agonist-induced increase in apparent β-adrenergic receptor size. Proc. Natl. Acad. Sci. U.S.A. 75, 228-232.
19. 2a receptors with a new radioligand, 2-[2-(4-amino-3-[125]iodophenyl)ethylamino]adenosine. J. Mol. Pharmacol. 47, 307-313.
20. 2 receptor with physiological constitutive activity. Biochem. Biophys. Res. Comm. 173, 1169-1178.
21. 2+ ion. Biochem. Biophys. Acta. 1220, 76-84.
22. McPherson, G.A., 1985. Analysis of radioligand binding experiments. J. PHarmacol. Methods 14, 213-228.
23. 2a adenosine receptor from guinea pig brain. Neurochem. Res. 19, 613-621.
24. Nakata, H., Fujisaka, H., 1983. Solubilization and partial characterization of adenosine binding sites from rat brain stem. FEBS Lett. 158, 93-97.
25. 2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis. Mol. Pharmacol. 39, 130-135.
26. 2-adenosine receptor. J. Receptor Res. 13, 961-973.
27. Olsson, R.A., Pearson, J.D., 1990. Cardiovascular purinoceptors. Physiol. Rev. 70, 761-845.
28. 2 receptor-mediated excitatory actions on the nervous system. Prog. Neurobiology 48, 167-189.
29. Smith, S.K., Lumbird, L.E., 1981. Solubilization of human platelet α-adrenergic receptors: evidence that agonist occupancy of the receptor stabilizes receptor-effector interaction. Proc. Natl. Acad. Sci. U.S.A. 78, 4026-4030.
30. 1 adenosine receptor; solubilization and characterization of a guanine nucleotide-sensitive form of the receptor. J. Biol. Chem. 260, 6728-6732.
31. Stiles, G.L., 1992. Adenosine receptors J. Biol. Chem. 267, 6451-6454.
32. 3H]CGS-21680 to human and rat brain: evidence for multiple affinity sites. J. Neurochem. 55, 1763-1771.